Creative Capital Management Investments LLC Aim Immuno Tech Inc. Transaction History

Creative Capital Management Investments LLC

  • $220 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 22, 2024
BUY
$0.32 - $0.77 $64 - $154
200 New
200 $0
Q4 2022

Jan 12, 2023
BUY
$0.31 - $0.6 $62 - $120
200 New
200 $0

Others Institutions Holding AIM

# of Institutions
36
Shares Held
9.01M
Call Options Held
0
Put Options Held
0
View Full List

About AIM ImmunoTech Inc.

AIM Quotes by TradingView
  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $9.61M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Creative Capital Management Investments LLC Portfolio

Follow Creative Capital Management Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Capital Management Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creative Capital Management Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email